Adoptive Transfer of Autoimmune Diabetes Using Immunodeficient Nonobese Diabetic (NOD) Mice
- PMID: 26791362
- DOI: 10.1007/7651_2015_294
Adoptive Transfer of Autoimmune Diabetes Using Immunodeficient Nonobese Diabetic (NOD) Mice
Abstract
Studying Type 1 Diabetes (T1D) in the nonobese diabetic (NOD) mouse model can be cumbersome as onset of disease does not usually occur naturally prior to the age of 12-14 weeks and is often restricted to female mice. Furthermore, the onset of disease occurs at random, which makes studying T1D in statistically meaningful cohorts of NOD mice a challenge. Transfer models of T1D into immunodeficient mice, such as NOD SCID mice, allows the study of potential therapeutic interventions in larger cohorts of animals, over shorter periods of time. In this chapter we discuss the adoptive transfer of diabetes into immunodeficient mice on the NOD genetic background that are generally available to the research community.
Keywords: Adoptive transfer models of type 1 diabetes; CD8 T cells; Intravenous cell transfer.
Similar articles
-
HLA-A2-matched peripheral blood mononuclear cells from type 1 diabetic patients, but not nondiabetic donors, transfer insulitis to NOD-scid/γc(null)/HLA-A2 transgenic mice concurrent with the expansion of islet-specific CD8+ T cells.Diabetes. 2011 Jun;60(6):1726-33. doi: 10.2337/db10-1287. Epub 2011 Apr 26. Diabetes. 2011. PMID: 21521873 Free PMC article.
-
Accelerated type 1 diabetes induction in mice by adoptive transfer of diabetogenic CD4+ T cells.J Vis Exp. 2013 May 6;(75):e50389. doi: 10.3791/50389. J Vis Exp. 2013. PMID: 23685789 Free PMC article.
-
Adoptive transfer of diabetes into immunodeficient NOD-scid/scid mice. Relative contributions of CD4+ and CD8+ T-cells from diabetic versus prediabetic NOD.NON-Thy-1a donors.Diabetes. 1993 Jan;42(1):44-55. doi: 10.2337/diab.42.1.44. Diabetes. 1993. PMID: 8093606
-
Control of type 1 autoimmune diabetes by naturally occurring CD4+CD25+ regulatory T lymphocytes in neonatal NOD mice.Ann N Y Acad Sci. 2005 Jun;1051:72-87. doi: 10.1196/annals.1361.048. Ann N Y Acad Sci. 2005. PMID: 16126946 Review.
-
Breaking T cell tolerance to beta cell antigens by merocytic dendritic cells.Cell Mol Life Sci. 2011 Sep;68(17):2873-83. doi: 10.1007/s00018-011-0730-6. Epub 2011 May 31. Cell Mol Life Sci. 2011. PMID: 21626409 Free PMC article. Review.
Cited by
-
Antigen-specific immunotherapy combined with a regenerative drug in the treatment of experimental type 1 diabetes.Sci Rep. 2020 Nov 3;10(1):18927. doi: 10.1038/s41598-020-76041-1. Sci Rep. 2020. PMID: 33144616 Free PMC article.
-
A human mutation in STAT3 promotes type 1 diabetes through a defect in CD8+ T cell tolerance.J Exp Med. 2021 Aug 2;218(8):e20210759. doi: 10.1084/jem.20210759. Epub 2021 Jun 11. J Exp Med. 2021. PMID: 34115115 Free PMC article.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials